| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.86 | 0.004 | 0.86 | Hypoglycemic | 0.833 0.004 DBMET01819 0.813 0.004 DBMET01820 0.457 0.02 DBMET00202 0.437 0.022 DBMET00203 0.497 0.015 DBMET00204 0.833 0.004 DBMET01329 0.813 0.004 DBMET01330 0.857 0.004 DBMET01328 | ||
| 0.694 | 0.004 | 0.694 | MAP kinase kinase 6 inhibitor | 0.628 0.005 DBMET01819 0.621 0.005 DBMET01820 0.628 0.005 DBMET01329 0.621 0.005 DBMET01330 0.645 0.005 DBMET01328 | ||
| 0.666 | 0.014 | 0.666 | Antiobesity | 0.631 0.017 DBMET01819 0.569 0.025 DBMET01820 0.351 0.087 DBMET00202 0.291 0.122 DBMET00203 0.384 0.072 DBMET00204 0.631 0.017 DBMET01329 0.569 0.025 DBMET01330 0.659 0.014 DBMET01328 | ||
| 0.62 | 0.024 | 0.692 | Cyclophilin D inhibitor | 0.657 0.019 DBMET01819 0.607 0.026 DBMET01820 0.291 0.171 DBMET00202 0.307 0.156 DBMET00204 0.657 0.019 DBMET01329 0.607 0.026 DBMET01330 0.692 0.015 DBMET01328 | DBMET01328 | |
| 0.537 | 0.005 | 0.537 | Platelet adhesion inhibitor | 0.532 0.005 DBMET01819 0.52 0.005 DBMET01820 0.328 0.025 DBMET00202 0.32 0.028 DBMET00203 0.299 0.034 DBMET00204 0.532 0.005 DBMET01329 0.52 0.005 DBMET01330 0.519 0.005 DBMET01328 | ||
| 0.48 | 0.003 | 0.48 | M18 aspartyl aminopeptidase inhibitor | 0.462 0.004 DBMET01819 0.454 0.004 DBMET01820 0.462 0.004 DBMET01329 0.454 0.004 DBMET01330 0.469 0.003 DBMET01328 | ||
| 0.478 | 0.032 | 0.626 | Antithrombotic | 0.589 0.017 DBMET01819 0.571 0.019 DBMET01820 0.391 0.052 DBMET00202 0.369 0.058 DBMET00203 0.377 0.055 DBMET00204 0.589 0.017 DBMET01329 0.571 0.019 DBMET01330 0.626 0.014 DBMET01328 | DBMET01328 | |
| 0.381 | 0.014 | 0.517 | Diuretic | 0.334 0.018 DBMET01819 0.328 0.018 DBMET01820 0.217 0.038 DBMET00202 0.212 0.04 DBMET00203 0.169 0.061 DBMET00204 0.334 0.018 DBMET01329 0.328 0.018 DBMET01330 0.517 0.007 DBMET01328 | DBMET01328 | |
| 0.362 | 0.004 | 0.362 | Cannabinoid receptor antagonist | 0.164 0.012 DBMET01819 0.093 0.032 DBMET01820 0.076 0.043 DBMET00204 0.164 0.012 DBMET01329 0.093 0.032 DBMET01330 0.137 0.017 DBMET01328 | ||
| 0.352 | 0.005 | 0.352 | Cyclin-dependent kinase 3 inhibitor | 0.311 0.008 DBMET01819 0.299 0.009 DBMET01820 0.158 0.079 DBMET00204 0.311 0.008 DBMET01329 0.299 0.009 DBMET01330 0.332 0.006 DBMET01328 | ||
| 0.396 | 0.076 | 0.396 | 15-Lipoxygenase inhibitor | 0.346 0.102 DBMET01819 0.212 0.2 DBMET01820 0.346 0.102 DBMET01329 0.212 0.2 DBMET01330 0.376 0.085 DBMET01328 | ||
| 0.32 | 0.004 | 0.32 | Cannabinoid CB1 receptor antagonist | 0.135 0.009 DBMET01819 0.084 0.024 DBMET01820 0.074 0.032 DBMET00204 0.135 0.009 DBMET01329 0.084 0.024 DBMET01330 0.113 0.013 DBMET01328 | ||
| 0.226 | 0.006 | 0.286 | Adenylate cyclase stimulant | 0.272 0.004 DBMET01819 0.286 0.003 DBMET01820 0.195 0.016 DBMET00202 0.205 0.012 DBMET00203 0.173 0.032 DBMET00204 0.272 0.004 DBMET01329 0.286 0.003 DBMET01330 0.205 0.011 DBMET01328 | DBMET01330 | |
| 0.276 | 0.059 | 0.357 | 5 Hydroxytryptamine uptake stimulant | 0.214 0.126 DBMET01819 0.201 0.149 DBMET01820 0.203 0.146 DBMET00204 0.214 0.126 DBMET01329 0.201 0.149 DBMET01330 0.357 0.024 DBMET01328 | DBMET01328 | |
| 0.2 | 0.009 | 0.234 | Carbonic anhydrase inhibitor | 0.225 0.007 DBMET01819 0.18 0.012 DBMET01820 0.144 0.017 DBMET00202 0.103 0.026 DBMET00203 0.125 0.02 DBMET00204 0.225 0.007 DBMET01329 0.18 0.012 DBMET01330 0.234 0.007 DBMET01328 | DBMET01328 | |
| 0.277 | 0.093 | 0.277 | 12-Lipoxygenase inhibitor | 0.197 0.155 DBMET01819 0.197 0.155 DBMET01329 0.242 0.114 DBMET01328 | ||
| 0.273 | 0.105 | 0.424 | Sodium/bile acid cotransporter inhibitor | 0.386 0.021 DBMET01819 0.411 0.014 DBMET01820 0.402 0.016 DBMET00202 0.424 0.011 DBMET00203 0.307 0.073 DBMET00204 0.386 0.021 DBMET01329 0.411 0.014 DBMET01330 0.336 0.049 DBMET01328 | DBMET00203 | |
| 0.168 | 0.004 | 0.168 | Potassium channel (ATP-sensitive) blocker | 0.155 0.005 DBMET01819 0.109 0.012 DBMET01820 0.066 0.048 DBMET00202 0.155 0.005 DBMET01329 0.109 0.012 DBMET01330 0.095 0.018 DBMET01328 | ||
| 0.193 | 0.039 | 0.23 | Insulin secretagoues | 0.195 0.039 DBMET01819 0.171 0.055 DBMET01820 0.228 0.024 DBMET00202 0.2 0.036 DBMET00203 0.229 0.024 DBMET00204 0.195 0.039 DBMET01329 0.171 0.055 DBMET01330 0.23 0.024 DBMET01328 | DBMET01328 | |
| 0.155 | 0.004 | 0.155 | Bombesin 3 receptor antagonist | 0.137 0.005 DBMET01819 0.131 0.005 DBMET01820 0.135 0.005 DBMET00202 0.129 0.005 DBMET00203 0.146 0.004 DBMET00204 0.137 0.005 DBMET01329 0.131 0.005 DBMET01330 0.149 0.004 DBMET01328 | ||
| 0.146 | 0.008 | 0.146 | Cannabinoid CB2 receptor antagonist | 0.062 0.028 DBMET01819 0.062 0.028 DBMET01329 | ||
| 0.133 | 0.005 | 0.133 | Potassium channel (Inward rectifier) blocker | 0.119 0.005 DBMET01819 0.074 0.015 DBMET01820 0.119 0.005 DBMET01329 0.074 0.015 DBMET01330 0.062 0.023 DBMET01328 | ||
| 0.21 | 0.086 | 0.21 | Potassium channel blocker | |||
| 0.133 | 0.012 | 0.167 | Carbonic anhydrase I inhibitor | 0.153 0.01 DBMET01819 0.111 0.016 DBMET01820 0.086 0.023 DBMET00202 0.059 0.036 DBMET00203 0.069 0.03 DBMET00204 0.153 0.01 DBMET01329 0.111 0.016 DBMET01330 0.167 0.008 DBMET01328 | DBMET01328 | |
| 0.133 | 0.014 | 0.142 | Carbonic anhydrase IX inhibitor | 0.089 0.023 DBMET01819 0.059 0.038 DBMET01820 0.069 0.033 DBMET00204 0.089 0.023 DBMET01329 0.059 0.038 DBMET01330 0.142 0.013 DBMET01328 | DBMET01328 | |
| 0.131 | 0.015 | 0.161 | Carbonic anhydrase XII inhibitor | 0.09 0.022 DBMET01819 0.048 0.04 DBMET01820 0.09 0.022 DBMET01329 0.048 0.04 DBMET01330 0.161 0.011 DBMET01328 | DBMET01328 | |
| 0.126 | 0.014 | 0.146 | Carbonic anhydrase II inhibitor | 0.146 0.01 DBMET01819 0.113 0.016 DBMET01820 0.084 0.024 DBMET00202 0.06 0.035 DBMET00203 0.068 0.03 DBMET00204 0.146 0.01 DBMET01329 0.113 0.016 DBMET01330 0.146 0.011 DBMET01328 | DBMET01328 | |
| 0.108 | 0.004 | 0.108 | Carbonic anhydrase I stimulant | 0.087 0.006 DBMET01819 0.079 0.007 DBMET01820 0.089 0.005 DBMET00202 0.081 0.007 DBMET00203 0.093 0.005 DBMET00204 0.087 0.006 DBMET01329 0.079 0.007 DBMET01330 0.096 0.005 DBMET01328 | ||
| 0.137 | 0.037 | 0.137 | CDK3/cyclin E inhibitor | 0.112 0.067 DBMET01819 0.099 0.089 DBMET01820 0.112 0.067 DBMET01329 0.099 0.089 DBMET01330 0.135 0.039 DBMET01328 | ||
| 0.101 | 0.005 | 0.101 | Carbonic anhydrase II stimulant | 0.084 0.008 DBMET01819 0.078 0.01 DBMET01820 0.087 0.007 DBMET00202 0.08 0.009 DBMET00203 0.091 0.006 DBMET00204 0.084 0.008 DBMET01329 0.078 0.01 DBMET01330 0.09 0.006 DBMET01328 | ||
| 0.203 | 0.113 | 0.203 | MAP kinase kinase 3 inhibitor | 0.183 0.179 DBMET01819 0.183 0.179 DBMET01329 | ||
| 0.183 | 0.095 | 0.721 | Platelet aggregation inhibitor | 0.18 0.097 DBMET01819 0.707 0.005 DBMET00202 0.641 0.005 DBMET00203 0.721 0.005 DBMET00204 0.18 0.097 DBMET01329 0.181 0.096 DBMET01328 | DBMET00204 | |
| 0.118 | 0.038 | 0.229 | Electrolyte absorption antagonist | 0.093 0.068 DBMET01819 0.086 0.082 DBMET00202 0.093 0.068 DBMET01329 0.229 0.005 DBMET01328 | DBMET01328 | |
| 0.097 | 0.026 | 0.136 | Carbonic anhydrase VA inhibitor | 0.071 0.045 DBMET01819 0.076 0.04 DBMET00202 0.061 0.059 DBMET00203 0.136 0.014 DBMET00204 0.071 0.045 DBMET01329 0.124 0.017 DBMET01328 | DBMET00204 | |
| 0.132 | 0.062 | 0.14 | CC chemokine 6 receptor antagonist | 0.127 0.083 DBMET01819 0.128 0.079 DBMET01820 0.132 0.063 DBMET00202 0.133 0.061 DBMET00203 0.13 0.069 DBMET00204 0.127 0.083 DBMET01329 0.128 0.079 DBMET01330 0.14 0.04 DBMET01328 | DBMET01328 | |
| 0.093 | 0.022 | 0.105 | Bcl2 antagonist | 0.082 0.03 DBMET01819 0.07 0.042 DBMET01820 0.095 0.021 DBMET00202 0.082 0.03 DBMET00203 0.105 0.015 DBMET00204 0.082 0.03 DBMET01329 0.07 0.042 DBMET01330 0.091 0.024 DBMET01328 | DBMET00204 | |
| 0.091 | 0.021 | 0.091 | Carbonic anhydrase stimulant | 0.062 0.039 DBMET01819 0.07 0.032 DBMET00202 0.054 0.048 DBMET00203 0.064 0.036 DBMET00204 0.062 0.039 DBMET01329 0.069 0.032 DBMET01328 | ||
| 0.091 | 0.03 | 0.156 | Carbonic anhydrase V inhibitor | 0.063 0.05 DBMET01819 0.068 0.044 DBMET00202 0.156 0.013 DBMET00204 0.063 0.05 DBMET01329 0.131 0.019 DBMET01328 | DBMET00204 | |
| 0.078 | 0.021 | 0.135 | Thromboxane antagonist | 0.075 0.023 DBMET01819 0.069 0.027 DBMET01820 0.072 0.024 DBMET00202 0.066 0.028 DBMET00203 0.092 0.014 DBMET00204 0.075 0.023 DBMET01329 0.069 0.027 DBMET01330 0.135 0.005 DBMET01328 | DBMET01328 | |
| 0.059 | 0.006 | 0.059 | Estrone sulfatase inhibitor | 0.033 0.01 DBMET01819 0.041 0.009 DBMET01820 0.033 0.01 DBMET01329 0.041 0.009 DBMET01330 0.054 0.007 DBMET01328 | ||
| 0.128 | 0.075 | 0.128 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.109 0.092 DBMET01819 0.109 0.092 DBMET01329 | ||
| 0.093 | 0.044 | 0.189 | Carbonic anhydrase VI inhibitor | 0.103 0.037 DBMET01819 0.104 0.037 DBMET01820 0.117 0.03 DBMET00202 0.118 0.03 DBMET00203 0.189 0.014 DBMET00204 0.103 0.037 DBMET01329 0.104 0.037 DBMET01330 0.17 0.017 DBMET01328 | DBMET00204 | |
| 0.138 | 0.092 | 0.176 | Anticoagulant | 0.13 0.1 DBMET01819 0.13 0.1 DBMET01329 0.176 0.063 DBMET01328 | DBMET01328 | |
| 0.072 | 0.033 | 0.072 | Cannabinoid CB1 receptor agonist | |||
| 0.062 | 0.027 | 0.101 | Thromboxane A2 antagonist | 0.059 0.029 DBMET01819 0.053 0.034 DBMET01820 0.067 0.023 DBMET00202 0.061 0.027 DBMET00203 0.082 0.014 DBMET00204 0.059 0.029 DBMET01329 0.053 0.034 DBMET01330 0.101 0.007 DBMET01328 | DBMET01328 | |
| 0.057 | 0.023 | 0.057 | Alpha 1b adrenoreceptor agonist | 0.047 0.045 DBMET00203 0.051 0.032 DBMET00204 | ||
| 0.038 | 0.004 | 0.038 | Carbonic anhydrase IV stimulant | 0.026 0.005 DBMET01819 0.023 0.005 DBMET01820 0.027 0.004 DBMET00202 0.024 0.005 DBMET00203 0.029 0.004 DBMET00204 0.026 0.005 DBMET01329 0.023 0.005 DBMET01330 0.031 0.004 DBMET01328 | ||
| 0.064 | 0.031 | 0.072 | Bcl-xL inhibitor | 0.058 0.047 DBMET01819 0.065 0.028 DBMET00202 0.061 0.037 DBMET00203 0.072 0.017 DBMET00204 0.058 0.047 DBMET01329 0.066 0.026 DBMET01328 | DBMET00204 | |
| 0.054 | 0.024 | 0.055 | Collagenase inhibitor | 0.05 0.032 DBMET01819 0.046 0.042 DBMET01820 0.051 0.03 DBMET00202 0.047 0.04 DBMET00203 0.052 0.029 DBMET00204 0.05 0.032 DBMET01329 0.046 0.042 DBMET01330 0.055 0.023 DBMET01328 | DBMET01328 | |
| 0.13 | 0.1 | 0.185 | Pregnane X receptor agonist | 0.139 0.075 DBMET01819 0.185 0.016 DBMET00202 0.162 0.035 DBMET00203 0.148 0.056 DBMET00204 0.139 0.075 DBMET01329 | DBMET00202 | |
| 0.047 | 0.017 | 0.058 | Aggrecanase 1 inhibitor | 0.038 0.029 DBMET01819 0.036 0.034 DBMET01820 0.043 0.021 DBMET00202 0.04 0.025 DBMET00203 0.058 0.009 DBMET00204 0.038 0.029 DBMET01329 0.036 0.034 DBMET01330 0.042 0.022 DBMET01328 | DBMET00204 | |
| 0.075 | 0.047 | 0.075 | Thrombin inhibitor | 0.067 0.06 DBMET00204 0.069 0.056 DBMET01328 | ||
| 0.067 | 0.043 | 0.067 | Cannabinoid receptor agonist | |||
| 0.133 | 0.109 | 0.209 | Mcl-1 antagonist | 0.209 0.051 DBMET01328 | DBMET01328 | |
| 0.052 | 0.033 | 0.161 | Prostaglandin E2 antagonist | 0.072 0.023 DBMET00204 0.161 0.008 DBMET01328 | DBMET01328 | |
| 0.058 | 0.042 | 0.058 | Cyclin H inhibitor | |||
| 0.057 | 0.041 | 0.057 | CDK4/cyclin D1 inhibitor | |||
| 0.058 | 0.042 | 0.058 | Cyclin E inhibitor | |||
| 0.048 | 0.032 | 0.049 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.049 0.03 DBMET01819 0.047 0.032 DBMET01820 0.049 0.031 DBMET00202 0.047 0.033 DBMET00203 0.049 0.03 DBMET01329 0.047 0.032 DBMET01330 | DBMET01329 | |
| 0.04 | 0.023 | 0.04 | Potassium channel Kv1.1 blocker | |||
| 0.018 | 0.005 | 0.018 | CC chemokine 10 receptor antagonist | 0.015 0.01 DBMET01819 0.016 0.007 DBMET00202 0.015 0.01 DBMET00203 0.018 0.006 DBMET00204 0.015 0.01 DBMET01329 0.015 0.012 DBMET01328 | ||
| 0.141 | 0.129 | 0.191 | Non-steroidal antiinflammatory agent | 0.164 0.1 DBMET01819 0.164 0.1 DBMET01329 0.191 0.079 DBMET01328 | DBMET01328 | |
| 0.071 | 0.06 | 0.135 | GABA aminotransferase inhibitor | 0.135 0.011 DBMET01328 | DBMET01328 | |
| 0.052 | 0.043 | 0.103 | Carbonic anhydrase VB inhibitor | 0.103 0.015 DBMET00204 0.07 0.028 DBMET01328 | DBMET00204 | |
| 0.057 | 0.05 | 0.057 | CDK1/cyclin B inhibitor | |||
| 0.07 | 0.064 | 0.083 | Vanilloid 4 agonist | 0.076 0.049 DBMET00202 0.083 0.035 DBMET00204 | DBMET00204 | |
| 0.194 | 0.189 | 0.194 | Beta lactamase inhibitor | |||
| 0.038 | 0.034 | 0.045 | Phenylethanolamine N methyltransferase inhibitor | 0.038 0.035 DBMET00202 0.045 0.021 DBMET00204 | DBMET00204 | |
| 0.066 | 0.062 | 0.135 | Carbonic anhydrase XIII inhibitor | 0.069 0.059 DBMET00202 0.135 0.025 DBMET00204 0.128 0.027 DBMET01328 | DBMET00204 | |
| 0.044 | 0.041 | 0.044 | Cyclin E1 inhibitor | |||
| 0.041 | 0.039 | 0.053 | Carbonic anhydrase VII inhibitor | 0.053 0.024 DBMET01328 | DBMET01328 | |
| 0.019 | 0.018 | 0.02 | Factor XIII inhibitor | 0.02 0.016 DBMET00204 | DBMET00204 | |
| 0.045 | 0.044 | 0.048 | HCV NS3/NS4A protease inhibitor | 0.048 0.037 DBMET01328 | DBMET01328 | |
| 0.148 | 0.147 | 0.238 | Platelet antagonist | 0.217 0.089 DBMET01819 0.162 0.132 DBMET01820 0.227 0.084 DBMET00202 0.17 0.126 DBMET00203 0.2 0.101 DBMET00204 0.217 0.089 DBMET01329 0.162 0.132 DBMET01330 0.238 0.078 DBMET01328 | DBMET01328 | |
| 0.055 | 0.056 | 0.09 | Prostaglandin F2 alpha antagonist | 0.069 0.034 DBMET01819 0.067 0.035 DBMET01820 0.081 0.022 DBMET00202 0.079 0.024 DBMET00203 0.061 0.045 DBMET00204 0.069 0.034 DBMET01329 0.067 0.035 DBMET01330 0.09 0.016 DBMET01328 | DBMET01328 | |
| 0.025 | 0.026 | 0.038 | Prostaglandin EP3 antagonist | 0.03 0.021 DBMET00202 0.038 0.015 DBMET00204 0.03 0.021 DBMET01328 | DBMET00204 | |
| 0.183 | 0.184 | 0.238 | Insulysin inhibitor | 0.238 0.108 DBMET01328 | DBMET01328 | |
| 0.02 | 0.021 | 0.024 | Angiotensin AT1A receptor antagonist | 0.021 0.017 DBMET00204 0.024 0.011 DBMET01328 | DBMET01328 | |
| 0.056 | 0.059 | 0.062 | Trypsin inhibitor | 0.057 0.056 DBMET00204 0.062 0.044 DBMET01328 | DBMET01328 | |
| 0.085 | 0.092 | 0.172 | Carbonic anhydrase XV inhibitor | 0.106 0.06 DBMET00202 0.172 0.024 DBMET00204 0.133 0.038 DBMET01328 | DBMET00204 | |
| 0.014 | 0.022 | 0.037 | Angiotensin AT2 receptor antagonist | 0.022 0.015 DBMET00204 0.037 0.012 DBMET01328 | DBMET01328 | |
| 0.039 | 0.05 | 0.084 | Carbonic anhydrase XIV inhibitor | 0.045 0.04 DBMET00202 0.072 0.019 DBMET00204 0.084 0.015 DBMET01328 | DBMET01328 | |
| 0.032 | 0.044 | 0.058 | Carbonic anhydrase IV inhibitor | 0.044 0.029 DBMET01819 0.058 0.02 DBMET00202 0.043 0.03 DBMET00203 0.043 0.03 DBMET00204 0.044 0.029 DBMET01329 0.041 0.032 DBMET01328 | DBMET00202 | |
| 0.043 | 0.057 | 0.052 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.052 0.04 DBMET00202 0.048 0.046 DBMET00203 0.048 0.046 DBMET00204 | DBMET00202 | |
| 0.05 | 0.064 | 0.066 | Neutrophil collagenase inhibitor | 0.066 0.043 DBMET00204 | DBMET00204 | |
| 0.026 | 0.044 | 0.07 | Farnesoid X receptor agonist | 0.053 0.013 DBMET01819 0.049 0.015 DBMET01820 0.07 0.007 DBMET00202 0.066 0.008 DBMET00203 0.047 0.017 DBMET00204 0.053 0.013 DBMET01329 0.049 0.015 DBMET01330 0.07 0.007 DBMET01328 | DBMET01328 | |
| 0.062 | 0.081 | 0.07 | Metalloproteinase-2 inhibitor | 0.07 0.066 DBMET00204 | DBMET00204 | |
| 0.02 | 0.045 | 0.075 | HCV NS5B polymerase inhibitor | 0.075 0.006 DBMET01328 | DBMET01328 | |
| 0.025 | 0.05 | 0.082 | RNA-directed RNA polymerase inhibitor | 0.082 0.006 DBMET01328 | DBMET01328 | |
| 0.03 | 0.057 | 0.046 | Glucose-6-phosphate dehydrogenase inhibitor | 0.045 0.015 DBMET01819 0.036 0.03 DBMET01820 0.046 0.015 DBMET00202 0.036 0.029 DBMET00203 0.045 0.015 DBMET01329 0.036 0.03 DBMET01330 | DBMET00202 | |
| 0.015 | 0.043 | 0.021 | Bombesin agonist | 0.021 0.019 DBMET01328 | DBMET01328 | |
| 0.127 | 0.163 | 0.183 | Phospholipase C inhibitor | 0.183 0.058 DBMET01819 0.171 0.071 DBMET01820 0.162 0.084 DBMET00202 0.152 0.103 DBMET00203 0.143 0.122 DBMET00204 0.183 0.058 DBMET01329 0.171 0.071 DBMET01330 0.167 0.077 DBMET01328 | DBMET01329 | |
| 0.025 | 0.07 | 0.048 | Angiotensin AT1 receptor antagonist | 0.04 0.033 DBMET00204 0.048 0.02 DBMET01328 | DBMET01328 | |
| 0.004 | 0.05 | 0.013 | Angiotensin AT1B receptor antagonist | 0.013 0.011 DBMET01328 | DBMET01328 | |
| 0.02 | 0.068 | 0.033 | AMPA receptor agonist | 0.033 0.029 DBMET00204 | DBMET00204 | |
| 0.07 | 0.118 | 0.101 | ABCA1 expression enhancer | 0.087 0.072 DBMET01820 0.087 0.072 DBMET01330 0.101 0.049 DBMET01328 | DBMET01328 | |
| 0.008 | 0.057 | 0.035 | Prostaglandin H2 antagonist | 0.035 0.009 DBMET01328 | DBMET01328 | |
| 0.028 | 0.077 | 0.087 | Prostaglandin antagonist | 0.046 0.043 DBMET00204 0.087 0.02 DBMET01328 | DBMET01328 | |
| 0.02 | 0.079 | 0.035 | Angiotensin II receptor antagonist | 0.035 0.023 DBMET01328 | DBMET01328 | |
| 0.055 | 0.122 | 0.124 | Aminopeptidase B inhibitor | 0.124 0.05 DBMET01328 | DBMET01328 | |
| 0.028 | 0.096 | 0.062 | CC chemokine 4 receptor antagonist | 0.062 0.015 DBMET00204 | DBMET00204 | |
| 0.012 | 0.082 | 0.025 | Prostaglandin EP4 antagonist | 0.025 0.02 DBMET01328 | DBMET01328 | |
| 0.009 | 0.079 | 0.025 | RNA-directed RNA polymerase stimulant | 0.025 0.024 DBMET00203 | DBMET00203 | |
| 0.035 | 0.11 | 0.059 | Thromboxane synthase inhibitor | 0.059 0.029 DBMET01328 | DBMET01328 | |
| 0.04 | 0.128 | 0.07 | Aminopeptidase I inhibitor | 0.07 0.054 DBMET01328 | DBMET01328 | |
| 0.011 | 0.102 | 0.035 | Glucocorticoid antagonist | 0.035 0.021 DBMET00203 | DBMET00203 | |
| 0.044 | 0.146 | 0.091 | Ca(v)2.2 blocker | 0.091 0.055 DBMET00203 | DBMET00203 | |
| 0.013 | 0.121 | 0.033 | Carnitine palmitoyltransferase 1 inhibitor | 0.033 0.025 DBMET01328 | DBMET01328 | |
| 0.009 | 0.119 | 0.021 | Isoleucine-tRNA ligase inhibitor | 0.021 0.02 DBMET00202 | DBMET00202 | |
| 0.057 | 0.171 | 0.126 | Carbonic anhydrase III inhibitor | 0.106 0.056 DBMET00202 0.102 0.06 DBMET00203 0.126 0.04 DBMET00204 0.09 0.074 DBMET01328 | DBMET00204 | |
| 0.011 | 0.131 | 0.032 | Carnitine palmitoyltransferase inhibitor | 0.032 0.027 DBMET01328 | DBMET01328 | |
| 0.046 | 0.171 | 0.09 | Protease inhibitor | 0.09 0.075 DBMET00203 | DBMET00203 | |
| 0.103 | 0.23 | 0.131 | MAP kinase kinase 4 inhibitor | 0.131 0.11 DBMET00202 0.127 0.124 DBMET01328 | DBMET00202 | |
| 0.039 | 0.167 | 0.083 | Glutamate dehydrogenase inhibitor | 0.083 0.042 DBMET01328 | DBMET01328 | |
| 0.031 | 0.175 | 0.059 | Glucosylceramidase inhibitor | 0.059 0.032 DBMET00202 0.057 0.035 DBMET00204 | DBMET00202 | |
| 0.078 | 0.223 | 0.147 | Hexokinase inhibitor | 0.143 0.087 DBMET00202 0.133 0.101 DBMET00204 0.147 0.082 DBMET01328 | DBMET01328 | |
| 0.052 | 0.203 | 0.187 | Amylase inhibitor | 0.187 0.049 DBMET00202 0.126 0.078 DBMET00203 0.149 0.064 DBMET00204 | DBMET00202 | |
| 0.066 | 0.263 | 0.164 | Anesthetic general | 0.135 0.131 DBMET01819 0.164 0.1 DBMET00202 0.135 0.131 DBMET01329 | DBMET00202 | |
| 0.071 | 0.284 | 0.151 | Aldehyde oxidase inhibitor | 0.151 0.138 DBMET01328 | DBMET01328 | |
| 0.079 | 0.341 | 0.293 | Lipocortins synthesis antagonist | 0.139 0.123 DBMET01819 0.269 0.028 DBMET01820 0.162 0.089 DBMET00202 0.293 0.022 DBMET00203 0.139 0.123 DBMET01329 0.269 0.028 DBMET01330 0.152 0.102 DBMET01328 | DBMET00203 | |
| 0.028 | 0.293 | 0.059 | Beta 2 adrenoreceptor agonist | 0.059 0.053 DBMET00204 | DBMET00204 | |
| 0.042 | 0.338 | 0.08 | Transcription factor NF kappa B stimulant | 0.08 0.069 DBMET00204 | DBMET00204 | |
| 0.031 | 0.373 | 0.066 | Lipocortins synthesis agonist | 0.064 0.029 DBMET01820 0.066 0.026 DBMET00203 0.064 0.029 DBMET01330 | DBMET00203 | |
| 0.039 | 0.412 | 0.129 | Farnesoid X receptor antagonist | 0.118 0.109 DBMET01819 0.129 0.084 DBMET00202 0.116 0.115 DBMET00203 0.118 0.109 DBMET01329 | DBMET00202 | |
| 0.054 | 0.443 | 0.128 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.128 0.122 DBMET01328 | DBMET01328 | |
| 0.103 | 0.52 | 0.543 | Antiinflammatory | 0.368 0.16 DBMET01820 0.415 0.13 DBMET00202 0.543 0.071 DBMET00203 0.397 0.141 DBMET00204 0.368 0.16 DBMET01330 | DBMET00203 | |
| 0.084 | 0.568 | 0.205 | Peptidyltransferase inhibitor | 0.181 0.127 DBMET01819 0.205 0.093 DBMET00202 0.179 0.13 DBMET00203 0.181 0.127 DBMET01329 | DBMET00202 | |
| 0.015 | 0.526 | 0.114 | Aminoacyl-tRNA synthetase inhibitor | 0.1 0.045 DBMET01820 0.114 0.033 DBMET00203 0.1 0.045 DBMET01330 | DBMET00203 | |
| 0.073 | 0.642 | 0.243 | Interleukin 2 agonist | 0.221 0.155 DBMET00202 0.201 0.188 DBMET00203 0.243 0.127 DBMET00204 | DBMET00204 | |
| 0.007 | 0.681 | 0.277 | Platelet activating factor antagonist | 0.235 0.019 DBMET00202 0.186 0.03 DBMET00203 0.277 0.013 DBMET00204 | DBMET00204 | |
| 0.034 | 0.771 | 0.129 | Growth hormone agonist | 0.129 0.109 DBMET00203 | DBMET00203 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |